Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GSK donates first clinical trial centre in Nigeria

This article was originally published in Scrip

Executive Summary

GlaxoSmithKlinehas donated the first state-of-the-art clinical trial centre in Nigeria at the Lagos State University College of Medicine. The site was selected from 92 universities and 19 colleges of medicine, and is fitted out with medical equipment and a 24-hour power supply. It will focus on the development of vaccines, as well as serving to improve Nigeria's reputation in health research. The chairman of the national health research ethics committee of Nigeria Professor Clement Adebamowo said that the centre would help promote Nigeria, and this would in turn generate "employment, new drugs and new discovery". Trials will start immediately with the recruitment of subjects for an ongoing global vaccine trial.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts